Published in J Am Geriatr Soc on April 01, 2000
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ (2012) 1.86
Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology (2013) 1.71
Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study. J Am Heart Assoc (2013) 0.99
Heart disease as a risk factor for dementia. Clin Epidemiol (2013) 0.89
Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system. Int Arch Med (2009) 0.84
Care transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safety. Ochsner J (2013) 0.82
Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy. J Neuroinflammation (2013) 0.80
Atrial fibrillation, cognitive impairment, and neuroimaging. Alzheimers Dement (2015) 0.76
Cognitive dysfunctions in intensive cardiac care unit. Indian J Psychiatry (2010) 0.76
Alteration of cerebrovascular haemodynamic patterns due to atrial fibrillation: an in silico investigation. J R Soc Interface (2017) 0.75
Prestroke dementia in patients with atrial fibrillation. Frequency and associated factors. J Neurol (2005) 0.75
In re atrial fibrillation and cognitive impairment. J Am Geriatr Soc (2001) 0.75
A Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation. J Surg (Northborough) (2013) 0.75
In re atrial fibrillation. J Am Geriatr Soc (2001) 0.75
Regarding atrial fibrillation and cognitive function in older people. J Am Geriatr Soc (2001) 0.75
Uncovering brain-heart information through advanced signal and image processing. Philos Trans A Math Phys Eng Sci (2016) 0.75
Editor's note. J Am Geriatr Soc (2000) 0.75
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry (2006) 2.48
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial. Aging Ment Health (2010) 2.46
Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol (1998) 2.38
Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc (1993) 2.02
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J (1998) 1.86
A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry (2005) 1.79
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology (1999) 1.78
Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol (1996) 1.74
Object and action naming in Alzheimer's disease and frontotemporal dementia [see comment]. Neurology (1998) 1.71
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiol Aging (2010) 1.63
Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol (1996) 1.60
Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A (1998) 1.58
MRI-based automated computer classification of probable AD versus normal controls. IEEE Trans Med Imaging (2008) 1.58
Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage (2010) 1.57
Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci (2001) 1.52
Depressive symptoms of Alzheimer caregivers are mainly due to personal rather than patient factors. Int J Geriatr Psychiatry (1998) 1.51
Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients. J Am Geriatr Soc (1996) 1.48
Effects of sensory aids on the quality of life and mortality of elderly people: a multivariate analysis. Age Ageing (1996) 1.43
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (2005) 1.40
Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord (1999) 1.37
Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology (1996) 1.36
Association between depressive symptoms and mortality in elderly people. Arch Intern Med (2001) 1.35
Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.34
Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol (1999) 1.32
Contrasting results between caregiver's report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver's personal characteristics. J Am Geriatr Soc (1999) 1.31
APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology (1999) 1.30
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29
Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients. Intensive Care Med (2008) 1.28
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27
Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 1.26
Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol (1999) 1.24
Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology. Neuropharmacology (1974) 1.23
Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. Arch Gerontol Geriatr (2007) 1.20
Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci (1978) 1.17
Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J Neurol (2007) 1.16
Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry (2000) 1.16
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry (2000) 1.16
Neuropsychological heterogeneity in mild Alzheimer's disease. Dementia (1994) 1.13
PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death Differ (2011) 1.11
Sensory impairments and mortality in an elderly community population: a six-year follow-up study. Age Ageing (1995) 1.07
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 1.06
Addendum to 'Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial' (Raglio et al., 2010). Aging Ment Health (2012) 1.06
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo. Neuroimage (2009) 1.05
Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol (1978) 1.05
Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia (1995) 1.05
LCC-Demons: a robust and accurate symmetric diffeomorphic registration algorithm. Neuroimage (2013) 1.05
Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry (1996) 1.04
MCI patients' EEGs show group differences between those who progress and those who do not progress to AD. Neurobiol Aging (2011) 1.04
Hippocampal shape differences in dementia with Lewy bodies. Neuroimage (2008) 1.03
The effect of chronic diseases on physical function. Comparison between activities of daily living scales and the Physical Performance Test. Age Ageing (1997) 1.03
An electronic memory aid to support prospective memory in patients in the early stages of Alzheimer's disease: a pilot study. Aging Ment Health (2003) 1.03
Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment. Neurobiol Aging (2010) 1.01
LEIPAD, an internationally applicable instrument to assess quality of life in the elderly. Behav Med (1998) 1.00
Principal lifetime occupation and sleep quality in the elderly. Gerontology (1996) 1.00
Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol (1996) 1.00
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology (2008) 1.00
Increase of theta/gamma ratio is associated with memory impairment. Clin Neurophysiol (2009) 0.99
Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology (1993) 0.99
Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease. Neurosci Lett (2002) 0.99
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology (2001) 0.98
Italian community norms for the Brief Symptom Inventory in the elderly. Br J Clin Psychol (1993) 0.98
Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools. J Neurol Neurosurg Psychiatry (2001) 0.98
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia (1994) 0.96
Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. J Neurol Neurosurg Psychiatry (2004) 0.96
Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ (2009) 0.96
Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res (1977) 0.96
Age-related adaptations of brain function during a memory task are also present at rest. Neuroimage (2011) 0.96
Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment. Clin Neurophysiol (2007) 0.96
EFNS task force: the use of neuroimaging in the diagnosis of dementia. Eur J Neurol (2012) 0.95
Specific EEG changes associated with atrophy of hippocampus in subjects with mild cognitive impairment and Alzheimer's disease. Int J Alzheimers Dis (2012) 0.95
The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology (2007) 0.95
The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol (1997) 0.95
Physical Performance Test and Activities of Daily Living scales in the assessment of health status in elderly people. J Am Geriatr Soc (1993) 0.95